市場調查報告書
商品編碼
1547994
全球合法大麻市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測Global Legal Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球合法大麻市場需求預計將從 2023 年的 207.8 億美元達到近 1,499.9 億美元的市場規模,2024-2032 年研究期間複合年成長率為 24.56%。
一些國家已將出於醫療和娛樂目的持有、分配、種植和消費大麻合法化。而且,在大多數國家,這些政策均受《聯合國麻醉藥品單一公約》監管。大麻在市場上有多種形式:花蕾、油和酊劑。這種精神活性藥物的醫學應用會導致慢性疼痛、精神障礙、癌症和其他神經系統疾病。大麻的成人用途包括用作食品成分和精神藥物。
隨著醫療和成人用途的合法大麻使用量激增,全球對其的需求預計將大幅增加。此外,對疼痛管理治療的需求不斷成長,加上老年族群慢性疼痛負擔的增加,預計將提高產品需求。然而,COVID-19大流行對消費者的購買能力和無縫貿易施加了一些限制。這是合法大麻市場面臨的主要挑戰。另一方面,大麻在治療多種疾病、癌症、焦慮症、帕金森氏症和阿茲海默症方面的應用範圍預計將預示著產品在全球市場的滲透。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球合法大麻市場的每個細分市場進行了包容性評估。合法大麻產業的成長和趨勢為本研究提供了整體方法。
合法大麻市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲合法大麻市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。合法大麻市場的主要參與者包括頂篷 Growth Corporation、Aurora Cannabis Inc.、Tilray Brands Inc. (Aphria Inc.)、Abcann Medicinals Inc. (Vivo Cannabis Inc.)、The Cronos Group、Maricann Inc.、 Organigram Holdings Inc. .、Lexaria Bioscience、Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)、Tikun Olam、United Cannabis Corporation。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Legal Marijuana Market is presumed to reach the market size of nearly USD 149.99 Billion by 2032 from USD 20.78 Billion in 2023 with a CAGR of 24.56% under the study period 2024-2032.
Several countries have legalized possession, distribution, cultivation, and consumption of marijuana for medical and recreational purposes. And, in most nations, these policies are regulated by the United Nations Single Convention on Narcotic Drugs. Marijuana is available in several forms in the market, buds, oil, and tinctures. The medical application of this psychoactive drug is subjected to chronic pain, mental disorders, cancer, and other neurological diseases. The Adult-use of marijuana can range from being used as a food ingredient to a psychoactive drug.
With the soar in the use of legal marijuana for medical and adult-use, the global demands for the same are anticipated to grow significantly. Moreover, the growing need for pain management treatments along with the rising burden of chronic pain among the geriatric population is anticipated to lift the product demand. However, the COVID-19 pandemic has imposed several restrictions in terms of the buying capability of consumers and seamless trade. This acts as a key challenge for the legal marijuana market. On the other side, the scope of marijuana in treating several ailments, cancer, anxiety, and Parkinson's and Alzheimer's disease is anticipated to bode well for product penetration in the global market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Legal Marijuana. The growth and trends of Legal Marijuana industry provide a holistic approach to this study.
This section of the Legal Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Legal Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Legal Marijuana market include Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands Inc. (Aphria Inc.), Abcann Medicinals Inc. (Vivo Cannabis Inc.), The Cronos Group, Maricann Inc., Organigram Holdings Inc., Lexaria Bioscience, Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.), Tikun Olam, United Cannabis Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.